CN118001354A - 一种治疗皮肤癣病的中药组合物及其应用 - Google Patents
一种治疗皮肤癣病的中药组合物及其应用 Download PDFInfo
- Publication number
- CN118001354A CN118001354A CN202311846241.3A CN202311846241A CN118001354A CN 118001354 A CN118001354 A CN 118001354A CN 202311846241 A CN202311846241 A CN 202311846241A CN 118001354 A CN118001354 A CN 118001354A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- cortex
- traditional chinese
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 208000002474 Tinea Diseases 0.000 title claims abstract description 46
- 206010012504 Dermatophytosis Diseases 0.000 title claims abstract description 32
- 241001460074 Microsporum distortum Species 0.000 title claims abstract description 32
- 210000003038 endothelium Anatomy 0.000 claims abstract description 17
- 241000239226 Scorpiones Species 0.000 claims abstract description 13
- 241000218682 Pseudolarix amabilis Species 0.000 claims abstract description 8
- 239000006071 cream Substances 0.000 claims description 32
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 7
- 239000009490 scorpio Substances 0.000 claims description 7
- 235000002566 Capsicum Nutrition 0.000 claims description 4
- 239000006002 Pepper Substances 0.000 claims description 4
- 235000016761 Piper aduncum Nutrition 0.000 claims description 4
- 235000017804 Piper guineense Nutrition 0.000 claims description 4
- 235000008184 Piper nigrum Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- -1 decoction Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 244000203593 Piper nigrum Species 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 abstract description 17
- 230000007803 itching Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 244000045947 parasite Species 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 235000007650 Aralia spinosa Nutrition 0.000 abstract description 5
- 241000949456 Zanthoxylum Species 0.000 abstract description 5
- 241000287828 Gallus gallus Species 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 78
- 206010015150 Erythema Diseases 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 231100000321 erythema Toxicity 0.000 description 20
- 206010030113 Oedema Diseases 0.000 description 18
- 241000700159 Rattus Species 0.000 description 18
- 241000700198 Cavia Species 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 241000700199 Cavia porcellus Species 0.000 description 11
- 206010070834 Sensitisation Diseases 0.000 description 11
- 230000008313 sensitization Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 206010040880 Skin irritation Diseases 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 231100000475 skin irritation Toxicity 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- 206010005913 Body tinea Diseases 0.000 description 7
- 241000130764 Tinea Species 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 201000003875 tinea corporis Diseases 0.000 description 7
- 206010059516 Skin toxicity Diseases 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 231100000438 skin toxicity Toxicity 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 230000002951 depilatory effect Effects 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000037380 skin damage Effects 0.000 description 5
- 238000010171 animal model Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 241000722363 Piper Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010058679 Skin oedema Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005485 electric heating Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 229960004125 ketoconazole Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 206010027654 Allergic conditions Diseases 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010051814 Eschar Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 208000028990 Skin injury Diseases 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 208000007712 Tinea Versicolor Diseases 0.000 description 2
- 206010067197 Tinea manuum Diseases 0.000 description 2
- 206010056131 Tinea versicolour Diseases 0.000 description 2
- 241000212749 Zesius chrysomallus Species 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 231100000333 eschar Toxicity 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001671204 Stemona Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011554 guinea pig model Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 231100000314 skin damage score Toxicity 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗皮肤癣病的中药组合物,是由以下重量份的组分制成:苦参20~40份,百部10~20份,苦槿皮10~20份,狼毒10~40份,全蝎3~12份,土荆皮20~40份,黄柏20~40份,白鲜皮20~40份,蛇床子20~40份,露蜂房10~20份,花椒10~20份,鸡内金10~20份。本发明的中药组合物中,苦参、黄柏、白鲜皮可清热燥湿,百部、苦槿皮、狼毒、土荆皮、蛇床子有杀虫止痒之效;再加以全蝎、露蜂房以祛风攻毒,鸡内金健脾祛风,花椒增加本方透皮之效,使全方更好地发挥清热燥湿,杀虫止痒的治疗作用。
Description
技术领域
本发明属于中药组合物技术领域,具体地说,涉及一种治疗皮肤癣病的中药组合物及其应用。
背景技术
癣是发生在表皮、毛发、指甲的浅部真菌性皮肤病。具有传染性、长期性和广泛性的特征,一直是皮肤病防治工作的重点。本病根据发生部位的不同,有不同的名称。如发于头部的白癣、黄癣,发于手部的手癣,发于面颈躯干等的体癣、花斑癣等。
中医认为本病的病因由生活起居不慎,感染真菌,复因风、湿、热邪外袭,郁于腠理,淫于皮肤所致晶病发于头皮、毛发,则发为白秃疮、肥疮;病发于趾丫,则发为脚湿气;发于手掌部,则为鹅掌风;发于体表、股阴间,则为紫白癜风、圆癣、阴癣等。如表现为发热起疹,瘙痒脱屑者,多为风热盛所致;若见渗流滋水,瘙痒结痂者,多为湿热盛引起;若见皮肤肥厚、燥裂、瘙痒者,多由郁热化燥,气血不和,肤失营养所致。
目前治疗以杀虫止痒为主,针对性的治疗,主要包括口服与外用药物,同时提高患者免疫力,防止传染与再次感染。
发明内容
为解决现有治疗中外用药易产生耐药性,口服药易产生药物性肝损的问题,本发明的目的是提供一种治疗皮肤癣病的中药组合物。
本发明的另一个目的是提供一种所述中药组合物在制备治疗皮肤癣病的药物中的应用。
为了实现上述目的,本发明采用的技术方案如下:
本发明的第一方面提供了一种治疗皮肤癣病的中药组合物,是由以下重量份的组分制成:
苦参20~40份,百部10~20份,苦槿皮10~20份,狼毒10~40份,全蝎3~12份,土荆皮20~40份,黄柏20~40份,白鲜皮20~40份,蛇床子20~40份,露蜂房10~20份,花椒10~20份,鸡内金10~20份。
所述治疗皮肤癣病的中药组合物是由以下重量份的组分制成:苦参30份,百部15份,苦槿皮15份,狼毒15份,全蝎6份,土荆皮30份,黄柏30份,白鲜皮30份,蛇床子30份,露蜂房15份,花椒15份,鸡内金15份。
所述治疗皮肤癣病的中药组合物是由以下重量份的组分制成:苦参20份,百部10份,苦槿皮10份,狼毒10份,全蝎3份,土荆皮20份,黄柏20份,白鲜皮20份,蛇床子20份,露蜂房10份,花椒10份,鸡内金10份。
所述治疗皮肤癣病的中药组合物是由以下重量份的组分制成:苦参40份,百部20份,苦槿皮20份,狼毒40份,全蝎12份,土荆皮40份,黄柏40份,白鲜皮40份,蛇床子40份,露蜂房20份,花椒20份,鸡内金20份。
本发明的治疗皮肤癣病的中药组合物中,君药为苦参,臣药为百部、苦槿皮、狼毒、土荆皮、蛇床子;佐药为全蝎、黄柏、白鲜皮、露蜂房、鸡内金;使药为花椒。
本发明的组方中各项药物的性味、归经和功用及常用剂量如下:
苦参:性味:苦,寒。归心、肝、胃、大肠、膀胱经。功用:清热燥湿,杀虫止痒。外用适量。
百部:性味:甘、苦,微温。归肺经。功用:杀虫灭虱。外用适量。
苦槿皮:性味:甘苦,性微寒。归大肠、肝、心、肺、胃、脾经。功用:清热利湿,杀虫止痒。外用适量。
狼毒:性味:苦、辛,平。有毒。归肺,脾、肝经。功用:泻水逐饮,破积杀虫。外用适量。
全蝎:性味:辛,平。有毒。归肝经。功用:息风止痉,攻毒散结。外用适量。
土荆皮:性味:辛,温。归肺、脾经。功用:杀虫疗癣,祛湿止痒。外用适量。
黄柏:性味:苦,寒。归肾、膀胱、大肠经。功用:清热燥湿,泻火解毒。外用适量。
白鲜皮:性味:苦,寒。归脾、胃、膀胱经。功用:清热利湿,解毒止痒。外用适量。
蛇床子:性味:辛、苦,温。有小毒。归肾经。功用:杀虫止痒,燥湿祛风。外用适量。
露蜂房:性味:甘,平。归胃经。功用:攻毒杀虫,祛风止痛。外用适量。
花椒:性味:辛,温。归脾、胃、肾经。功用:燥湿杀虫止痒。外用适量。
鸡内金:性味:甘,平。归脾、胃、小肠、膀胱经。功用:消食健胃,化石通淋。外用适量。
方解:本方以苦参为君药清热燥湿统领全方,臣以百部、苦槿皮、狼毒、土荆皮、蛇床子以发挥杀虫止痒之功;并佐全蝎、露蜂房以祛风攻毒,黄柏、白鲜皮以清热燥湿止痒,鸡内金健脾祛风,最后以花椒为使增加本方透皮之效。全方共奏清热燥湿,杀虫止痒之效。
本发明的第二方面,提供了一种所述中药组合物在制备治疗皮肤癣病的药物中的应用。
本发明的第三方面,提供了一种由上述中药组合物制备的中药制剂,所述中药制剂的剂型选自乳膏、水煎剂、片剂、合剂、口服液、颗粒剂、丸剂、胶囊剂、脐贴、栓剂。
由于采用上述技术方案,本发明具有以下优点和有益效果:
本发明的中药组合物中,苦参、黄柏、白鲜皮可清热燥湿,百部、苦槿皮、狼毒、土荆皮、蛇床子有杀虫止痒之效;再加以全蝎、露蜂房以祛风攻毒,鸡内金健脾祛风,花椒增加本方透皮之效,使全方更好地发挥清热燥湿,杀虫止痒的治疗作用。
本发明的中药组合物乳膏适用于治疗如体癣、手癣、足癣等皮肤癣病,其疗效好,对于体癣豚鼠模型的红斑、丘疹、脱屑都有明显改善,能够抑制小鼠皮损部位的菌丝孢子生长,有较好的抗真菌作用,且无明显的皮肤毒性及刺激性。
附图说明
图1是给药后豚鼠皮肤情况的示意图。
图2是各组豚鼠皮损评分结果示意图。
图3是给药后豚鼠皮肤样本培养结果示意图。
图4是给药后豚鼠皮肤样本培养染色分析结果示意图。
图5是大鼠皮肤毒性实验结果示意图。
图6是大鼠涂抹中药组合物乳膏72h后皮肤刺激性情况结果示意图。
具体实施方式
为了更清楚地说明本发明,下面结合优选实施例对本发明做进一步的说明。本领域技术人员应当理解,下面所具体描述的内容是说明性的而非限制性的,不应以此限制本发明的保护范围。
实施例1
一种治疗皮肤癣病的中药组合物是由以下质量的组分制成:
苦参30g,百部15g,苦槿皮15g,狼毒15g,全蝎6g,土荆皮30g,黄柏30g,白鲜皮30g,蛇床子30g,露蜂房15g,花椒15g,鸡内金15g。
一种治疗皮肤癣病的中药组合物乳膏的制备方法包括以下步骤:
第一步,分别称取苦参、百部、苦槿皮、狼毒、全蝎、土荆皮、黄柏、白鲜皮、蛇床子、露蜂房、花椒、鸡内金,初步混合后,使用高速粉碎机将药材进行粗粉碎后称重,加入药粉质量20倍量的蒸馏水,用高温电热套加热提取1.5h,水煎液静置,离心收集水煎液后过滤2次。共重复(每次均加入20倍量水)煎煮提取3次。将三次获得的水煎液合并,经旋转蒸发仪60℃真空动态浓缩得流浸膏。
第二步,按油相:冰片1g、石蜡1g、蜂蜡1g、液体石蜡5g、单硬脂酸甘油脂2.4g、白凡士林1g、司盘-800.4g;水相:第一步获得流浸膏4g、白矾0.6g、吐温-80 0.2g、2%NaOH水溶液10g的比例称取各组分。将油水两相分别置于80℃水浴下均匀液化,趁热将油相倾入水相,用高速分散均质机以3000r/min乳化5min,得到棕黄色乳膏。
实施例2
一种治疗皮肤癣病的中药组合物是由以下质量的组分制成:
苦参20g,百部10g,苦槿皮10g,狼毒10g,全蝎3g,土荆皮20g,黄柏20g,白鲜皮20g,蛇床子20g,露蜂房10g,花椒10g,鸡内金10g。
一种治疗皮肤癣病的中药组合物水煎剂的制备方法包括以下步骤:
第一步,分别称取苦参、百部、苦槿皮、狼毒、全蝎、土荆皮、黄柏、白鲜皮、蛇床子、露蜂房、花椒、鸡内金,初步混合后,使用高速粉碎机将药材进行粗粉碎后称重。
第二部,加入药粉质量10倍量的蒸馏水充分浸泡30min,用高温电热套加热提取1h,水煎液静置,离心收集水煎液后过滤。重复以上煎煮离心过滤1次后,将两次过滤获得的水煎液混合,得到中药组合物水煎剂。
实施例3
一种治疗皮肤癣病的中药组合物是由以下质量的组分制成:
苦参40g,百部20g,苦槿皮20g,狼毒40g,全蝎12g,土荆皮40g,黄柏40g,白鲜皮40g,蛇床子40g,露蜂房20g,花椒20g,鸡内金20g。
一种治疗皮肤癣病的中药组合物颗粒剂的制备方法包括以下步骤:
第一步,分别称取苦参、百部、苦槿皮、狼毒、全蝎、土荆皮、黄柏、白鲜皮、蛇床子、露蜂房、花椒、鸡内金,初步混合后,使用高速粉碎机将药材进行粗粉碎后称重,加入药粉质量20倍量的蒸馏水,用高温电热套加热提取1.5h,水煎液静置,离心收集水煎液后过滤。按以上煎煮方法重复煎煮3次后,混合所得水煎液。将三次获得的水煎液合并得到混合水煎液。
第二步,将混合水煎液进行真空冷冻干燥得到中药复方冻干粉,将冻干粉、糖粉、糊精按1:2:4的重量比混合并过筛得到干混物,进一步真空干燥至恒重,得到中药组合物颗粒剂。
实施例4
治疗皮肤癣病的中药组合物乳膏在治疗皮肤癣病动物模型中的应用:
一、皮肤癣病动物实验模型制备:
取普通级健康豚鼠24只,饲养7天后适应实验环境,按照体重随机分为4组,每组10只,分别命名为:空白组、模型组、阳性对照组(酮康唑乳膏)、治疗组(实施例1制备的中药组合物乳膏)。将豚鼠背部一侧毛发剪短,面积约为4cm×4cm,然后再对应剪毛处涂抹适量的脱毛膏,数分钟后用温水将脱毛膏擦洗干净,豚鼠脱毛后检查脱毛处的皮肤是否出现损伤或药物残留;10%水合氯醛溶液麻醉,用无菌砂纸打磨皮肤至出血,用75%的乙醇消毒该部位;待消毒部位干燥后,配制1×108CFU/mL浓度的须癣毛癣菌混悬液300μL均匀涂布于破损皮肤表面。见皮肤出现明显红斑、鳞屑等体癣特征,表明体癣豚鼠模型制备成功。
二、动物实验给药方法及皮肤病变情况:
模型制备成功后,开始给予相应药物外涂于豚鼠背侧皮肤。空白组不予处理,模型组给予纯水1mg,阳性对照组给予酮康唑乳膏1mg,治疗组给予实施例1制备的中药组合物乳膏1mg,每日两次,连续14天。每日观察接种部位皮肤的改变,并进行评估,14天后各组皮肤情况如图1所示,图1是给药后豚鼠皮肤情况的示意图。
皮肤病变包括红斑面积,丘疹的数目、鱗屑的严重程度进行评分。将各组每只动物的皮肤病变的各类评分相加,各组之间进行比较。治疗14天后,皮损评分结果如图2所示,图2是各组豚鼠皮损评分结果示意图。从图中可以看出,模型组皮损评分仍明显高于空白组,而治疗组与阳性对照组可明显改善豚鼠体癣皮损情况,并且治疗组治疗效果优于阳性对照组。
皮损评分标准如表1所示:
表1
各组的结果如表2所示:
表2
空白组 | 模型组 | 治疗组 | 酮康唑乳膏 | |
红斑 | 0±0 | 2.2±0.42## | 0.7±0.67** | 0.9±0.74** |
鳞屑 | 0±0 | 2.6±0.52## | 0.9±0.74** | 1.1±0.74** |
丘疹 | 0±0 | 1.7±0.67## | 0.4±0.52** | 0.5±0.53** |
总分 | 0±0 | 6.5±1.18## | 2.0±1.15** | 2.5±1.35** |
注:与空白组相比,##P<0.01;与模型组相比,**P<0.01。
三、皮肤样本培养
治疗结束后棉签蘸取皮肤损伤处,接种沙堡葡萄糖琼脂斜面培养基,检测有无菌落增殖;通过玻片刮取皮肤组织样本,进行吉姆萨染色,观察有无孢子。
结果如图3和图4所示,图3是给药后豚鼠皮肤样本培养结果示意图。图4是给药后豚鼠皮肤样本培养染色分析结果示意图。图3结果显示除模型组外,其他组均无明显孢子或菌落长出,说明治疗组及阳性对照组均有较好的抗真菌作用。图4染色结果显示模型组有较多菌丝孢子长出,而治疗组及阳性对照组均无明显孢子或菌落长出,有较好的抗真菌作用。
实施例5
治疗皮肤癣病的中药组合物乳膏对实验动物皮肤毒性研究:
一、皮肤毒性实验
挑选健康SD大鼠50只,雄雌各半,于给药前24h去除大鼠背部3cm×3cm区域内的毛发,分为5组,每组10只。将赋形剂按1g/只的剂量涂在脱毛区域,为空白对照组;将实施例1制备的中药组合物乳膏以3g/只的剂量涂在脱毛区,为高剂量完整皮肤组;将中药组合物乳膏以3g/只的剂量涂在脱毛区破损皮肤,为高剂量破损皮肤组;将中药组合物乳膏以1g/只的剂量涂在脱毛区,为低剂量完整皮肤组;将中药组合物乳膏以1g/只的剂量涂在脱毛区破损皮肤,为低剂量破损皮肤组。24h后用温水去除受试物,观察,然后涂抹相同受试物,连续7d,观察大鼠全身表现和中毒死亡情况,包括动物的体重、脱毛区皮肤红肿程度、毛发、眼睛和黏膜的变化,呼吸、循环、中枢神经系统、四肢活动等的变化。
中药组合物乳膏对SD大鼠皮肤毒性的影响结果见图5所示,图5是大鼠皮肤毒性实验结果示意图。其中,a是空白对照组的皮肤;b是高剂量破损皮肤组的皮肤;c是低剂量破损皮肤组的皮肤;d是高剂量完整皮肤组的皮肤;e是低剂量完整皮肤组的皮肤。结果显示,外用中药组合物乳膏7天后,高剂量完整皮肤组、低剂量完整皮肤组的大鼠未见明显异常反应,精神状态、自主运动、眼睛、毛发、皮肤黏膜、呼吸等均未见异常;空白对照组的局部皮肤未见红斑、水肿,死亡情况;高剂量破损皮肤组、低剂量破损皮肤组的原有皮肤划痕处出现轻微红肿,划痕周围的皮肤未见红斑、水肿等,无死亡情况。如表3所示,所有的实验动物的体重正常增长,与空白对照组的实验动物数据对比无差别(P>0.05)。以上结果表示,实施例1制备的中药组合物乳膏对普通SD大鼠的皮肤毒性极小甚至不产生毒性。
表3中药组合物乳膏局部用药对大鼠体重的影响
二、皮肤刺激性试验
挑选健康SD大鼠20只,雄雌兼用,于给药前24h去除大鼠左右两侧3cm×3cm区域内的毛发,分为2组,每组10只,采用16号针头在麻醉、脱毛且消毒的皮肤上划“#”字至皮肤渗血以破损皮肤。
将赋形剂以1g/只的剂量涂在左侧脱毛完整皮肤区域,将实施例1制备的中药组合物乳膏以1g/只的剂量涂在右侧脱毛完整皮肤区域,为中药组合物乳膏完整皮肤组;将赋形剂以1g/只的剂量涂在左侧脱毛破损皮肤区域,将中药组合物乳膏以1g/只涂在右侧脱毛破损皮肤区域,为中药组合物乳膏破损皮肤组。24h后用温水去除受试物,观察,然后涂抹相同受试物,连续3d。并于末次涂药后1h、24h、48h、72h观察豚鼠脱毛区皮肤的刺激程度。
皮肤刺激性反应评分重点观察红斑、水肿情况,皮肤红斑反应分为5种情况:无红斑记0分,轻度红斑(勉强可见)记1分,中度红斑(明显可见)记2分,重度红斑记3分,紫红色红斑到轻度焦痂形成记4分。皮肤水肿反应分为5种情况:无水肿记0分,轻度水肿(勉强可见)记1分,中度水肿(明显可见)记2分,重度水肿(皮肤隆起约1mm,轮廓清晰)记3分,严重水肿(皮肤隆起1mm以上并且有扩大)记4分。强度评价:刺激指数平均分值=(红斑总分+水肿总分)/动物数量,分值≤0.49为无刺激性,分值0.5~2.99为轻度刺激性,分值3.0~5.99为中度刺激性;分值6.0~8.0为强刺激性。
皮肤刺激情况结果见图6所示,图6是大鼠涂抹中药组合物乳膏72h后皮肤刺激性情况结果示意图。其中,a是中药组合物乳膏破损皮肤组中左侧脱毛破损皮肤区域的皮肤;b是中药组合物乳膏破损皮肤组中右侧脱毛破损皮肤区域的皮肤;c是中药组合物乳膏完整皮肤组中左侧脱毛完整皮肤区域的皮肤;d是中药组合物乳膏完整皮肤组中右侧脱毛完整皮肤区域的皮肤。结果显示,经观察,受试大鼠中药组合物乳膏完整皮肤组在涂抹了中药组合物乳膏,清除受试物后1h、24h、48h、72h的四个时间段里,均未出现红斑或水肿等情况,皮肤形态与涂抹赋形剂的区域一样,该组平均反应刺激强度分值小于0.5分;受试大鼠中药组合物乳膏破损皮肤组除无菌注射针头划伤正常皮肤后出现的暗红色结痂,在涂抹中药组合物乳膏,清除受试物后在1h、24h、48h、72h四个时间段里,均未出现红斑或水肿等情况,皮肤形态与涂抹赋形剂的区域一样,该组平均反应刺激强度分值同样小于0.5分。以上结果表示中药组合物乳膏对正常皮肤和破损皮肤无刺激性。
皮肤刺激性反应评分的分值如表4和表5所示:
表4
表5
三、皮肤过敏性实验
取健康豚鼠30只,雌雄各半,随机分为3组,每组10只,于试验前24h,去除豚鼠背部皮肤3cm×3cm区域内的毛发,分别为空白对照组、实施例1制备的中药组合物乳膏组和阳性物对照组。
将赋型剂以1g/只的剂量涂在脱毛区域,为空白对照组;将中药组合物乳膏以1g/只的剂量涂在脱毛皮肤区域,为中药组合物乳膏组;将浓度为1%的DNCB(1-氯-2,4-二硝基苯)以0.1mL/只的剂量涂在脱毛皮肤区域,为阳性物对照组,用胶带固定,持续6h,分别于第7天、第14天以同样方法重复给药。
致敏接触末次涂抹药物后14d,分别于豚鼠的脱毛区域继续涂抹中药组合物乳膏以及赋型剂约0.3g/只,浓度为0.1%的DNCB约0.1mL/只,于6h后用温水洗净受试物,分别在即刻、24h、48h、72h四个时间段观察豚鼠过敏情况,包括局部皮肤红斑、水肿情况及是否存在呼吸困难、异常活动等全身性过敏反应。
皮肤过敏性反应评分主要根据红斑、水肿进行。皮肤红斑分为五种情况:无红斑计0分,轻度红斑(勉强可见)计1分,中度红斑(明显可见)计2分,重度红斑计3分,紫红色红斑到轻度焦痂形成计4分。皮肤水肿反应分为5种情况:无水肿计0分,轻度水肿(勉强可见)计1分,中度水肿(明显可见)计2分,重度水肿(皮肤隆起约1mm,轮廓清晰)计3分,严重水肿(皮肤隆起1mm以上并有扩大)计4分。
致敏性根据致敏发生率进行推算。致敏反应发生率=发生过敏反应动物数/动物总数×100%。致敏发生率(%):0-10为无致敏性,11-30为轻度致敏性,31-60为中度致敏性,61-80为重度致敏性,81-100为极度致敏性。
实验结果表明,中药组合物乳膏组以及空白对照组的豚鼠局部皮肤均未见红斑、水肿或呼吸困难、异常活动等全身过敏反应出现,致敏率为0。阳性物对照组的豚鼠在激发接触用药6h后,观察记录即刻、24h、48h、72h、7d、14d,过敏平均分值为1.67±0.52、1.17±0.41、1±0.63、0.5±0.55、0.33±0.52、0.17±0.41,致敏率达100%。
结果见表6所示:
表6
综上所述,本发明成功制备了中药组合物乳膏,并基于皮肤癣病动物实验模型,开展了豚鼠体癣治疗研究,发现其治疗效果显著,优于阳性对照药。并进行了皮肤急性毒性、皮肤刺激性和皮肤过敏性实验,结果均表明该中药组合物乳膏对皮肤组织无毒性、刺激性和过敏性。本发明为中药复方外用制剂治疗皮肤癣病提供了依据。
以上所述仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专利的技术人员在不脱离本发明技术方案范围内,当可利用上述提示的技术内容作出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案的内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明方案的范围内。
Claims (7)
1.一种治疗皮肤癣病的中药组合物,其特征在于,是由以下重量份的组分制成:
苦参20~40份,百部10~20份,苦槿皮10~20份,狼毒10~40份,全蝎3~12份,土荆皮20~40份,黄柏20~40份,白鲜皮20~40份,蛇床子20~40份,露蜂房10~20份,花椒10~20份,鸡内金10~20份。
2.根据权利要求1所述的治疗皮肤癣病的中药组合物,其特征在于,所述治疗皮肤癣病的中药组合物是由以下重量份的组分制成:苦参30份,百部15份,苦槿皮15份,狼毒15份,全蝎6份,土荆皮30份,黄柏30份,白鲜皮30份,蛇床子30份,露蜂房15份,花椒15份,鸡内金15份。
3.根据权利要求1所述的治疗皮肤癣病的中药组合物,其特征在于,所述治疗皮肤癣病的中药组合物是由以下重量份的组分制成:苦参20份,百部10份,苦槿皮10份,狼毒10份,全蝎3份,土荆皮20份,黄柏20份,白鲜皮20份,蛇床子20份,露蜂房10份,花椒10份,鸡内金10份。
4.根据权利要求1所述的治疗皮肤癣病的中药组合物,其特征在于,所述治疗皮肤癣病的中药组合物是由以下重量份的组分制成:苦参40份,百部20份,苦槿皮20份,狼毒40份,全蝎12份,土荆皮40份,黄柏40份,白鲜皮40份,蛇床子40份,露蜂房20份,花椒20份,鸡内金20份。
5.一种权利要求1至4任一项所述的中药组合物在制备治疗皮肤癣病的药物中的应用。
6.一种由权利要求1至4任一项所述的中药组合物制备的中药制剂。
7.根据权利要求6所述的中药制剂,其特征在于,所述中药制剂的剂型选自乳膏、水煎剂、片剂、合剂、口服液、颗粒剂、丸剂、胶囊剂、脐贴、栓剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311846241.3A CN118001354A (zh) | 2023-12-29 | 2023-12-29 | 一种治疗皮肤癣病的中药组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311846241.3A CN118001354A (zh) | 2023-12-29 | 2023-12-29 | 一种治疗皮肤癣病的中药组合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118001354A true CN118001354A (zh) | 2024-05-10 |
Family
ID=90952746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311846241.3A Pending CN118001354A (zh) | 2023-12-29 | 2023-12-29 | 一种治疗皮肤癣病的中药组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118001354A (zh) |
-
2023
- 2023-12-29 CN CN202311846241.3A patent/CN118001354A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110787114A (zh) | 一种去屑止痒控油的泡沫洗发液及其制备方法 | |
CN105251011B (zh) | 一种用于浅度烧伤的喷膜剂及其制备方法 | |
CN113398237B (zh) | 一种抗菌止痒止屑的中药组合物及其制备方法 | |
CA2766630C (en) | Anti-wart pharmaceutical composition and method for treating wart | |
CN105362410B (zh) | 一种治疗烧烫伤的中药制剂及制备方法 | |
CN117064979B (zh) | 一种防治银屑病的外用生肤油及其制备方法和应用 | |
CN105943666B (zh) | 一种用于婴幼儿敏感肌肤护理的组合物及其制备方法 | |
CN102872335B (zh) | 一种治疗糖尿病足的外用中药制剂及其制备方法 | |
CN116115707B (zh) | 防治奶牛腐蹄病的浓缩型泡沫药浴液及其制备方法 | |
JP6590233B1 (ja) | 皮膚疾患治療剤及びその製造方法 | |
CN103721138B (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN118001354A (zh) | 一种治疗皮肤癣病的中药组合物及其应用 | |
CN110721274B (zh) | 一种外用止痒剂及其制备方法 | |
CN108403872B (zh) | 一种驱风除湿祛疼痛草本精华液 | |
CN103920124B (zh) | 一种杀菌护肤冻疮膏 | |
CN102145072A (zh) | 一种治疗小儿湿疹及皮炎类皮肤病的中药组合物 | |
CN107714834A (zh) | 一种山茶油外用制剂的组合物、制备方法及其应用 | |
CN116159086B (zh) | 一种抑菌消炎止痒中药乳膏及其制备方法 | |
CN108066518A (zh) | 一种犬用中药浴液组合物及其制备方法 | |
RU2238754C1 (ru) | Сбор "прасковья" и способ лечения кожных заболеваний при фитопаротерапии | |
CN101940652A (zh) | 治疗牛皮癣、各种顽癣、瘙痒症的中药擦剂 | |
CN104547342A (zh) | 临床护理用快速止血的外敷散剂及制备方法 | |
CN117398437A (zh) | 一种治疗银屑病的中药复方外用凝胶 | |
CN112741863A (zh) | 一种治疗皮肤创伤的药物及其制备方法 | |
KR100470348B1 (ko) | 항진균성 효과를 나타내는 소리쟁이 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |